Torsemide

This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition

Issued and maintained by the United States Pharmacopeial Convention (USP)

DOWNLOAD PDF HERE

C₁₆H₂₀N₄O₃S 348.42

3-Pyridinesulfonamide, N-[[(1-methylethyl)amino]carbonyl]-4-[(3-methylphenyl)amino]-.

1-Isopropyl-3-[(4-m-toluidino-3-pyridyl)sulfonyl]urea CAS RN®: 56211-40-6; UNII: W31X2H97FB.

Torsemide contains not less than 98.0 percent and not more than 102.0 percent of C₁₆H₂₀N₄O₃S, calculated on the anhydrous basis.

1 Packaging and storage

Preserve in well-closed containers.

1.1 USP Reference standards 〈11〉

USP Torsemide RS (Form 1)

USP Torsemide Related Compound A RS

4-[(3-Methylphenyl)amino]-3-pyridinesulfonamide.

C₁₂H₁₃N₃O₂S 263.32

USP Torsemide Related Compound B RS

N-[(n-Butylamino)carbonyl]-4-[(3-methylphenyl)amino]-3-pyridinesulfonamide].

C₁₇H₂₂N₄O₃S 362.45

USP Torsemide Related Compound C RS

N-[(Ethylamino)carbonyl]-4-[(3-methylphenyl)amino]-3-pyridinesulfonamide.

C₁₅H₁₈N₄O₃S 334.39

2 Identification

Change to read:

A: Spectroscopic Identification Tests 〈197〉, Infrared Spectroscopy: 197K.

B: The retention time of the major peak in the chromatogram of the Assay preparation corresponds to that in the chromatogram of the Standard preparation, as obtained in the Assay.

Water Determination, Method I 〈921〉: not more than 1.0%.

Residue on ignition 〈281〉: not more than 0.1%.

3 Related compounds

0.02 M Potassium phosphate buffer and Mobile phase- Prepare as directed in the Assay.

Resolution solution - Transfer about 3 mg each of USP Torsemide RS and USP Torsemide Related Compound A RS to a 10-mL volumetric flask, add 3 mL of methanol, mix, and sonicate for not less than 8 minutes. Add 4.5 mL of 0.02 M Potassium phosphate buffer, cool to room temperature, dilute with Mobile phase to volume, and mix.

Standard solution - Transfer about 8 mg each of USP Torsemide Related Compound A RS, USP Torsemide Related Compound B RS, and USP Torsemide Related Compound C RS, accurately weighed, to a 100-mL volumetric flask, add 30 mL of methanol, mix, and sonicate for not less than 8 minutes. Add 45 mL of 0.02 M Potassium phosphate buffer, cool to room temperature, dilute with Mobile phase to volume, and mix. Quantitatively dilute a portion of this solution with Mobile phase to obtain a solution having a known concentration of about 0.0019 mg/mL.

Test solution - Use the Assay preparation.

Chromatographic system - Prepare as directed in the Assay. Chromatograph the Resolution solution and the Standard solution, and record the peak responses over a period three times the retention time of torsemide as directed for Procedure: the resolution, R, between torsemide and torsemide related compound A is not less than 1.0; the tailing factors are not more than 2.0; and the relative standard deviation for replicate injections is not more than 10.0%.

Procedure - Separately inject equal volumes (about 20 µL) of the Standard solution and the Test solution into the chromatograph, record the chromatograms, and measure the peak areas for torsemide related compound A, torsemide related compound B, and torsemide related compound C. Calculate the percentage of each related compound, if present, in the portion of Torsemide taken by the formula:

100(Cₛ/Cᵤ)(rᵤ/rₛ)

in which Cₛ is the concentration, in mg/mL, of the relevant USP Reference Standard in the Standard solution; Cᵤ is the concentration of Torsemide, in mg/mL, in the Test solution; and rᵤ and rₛ are the peak areas for the relevant torsemide related compound obtained from the Test solution and the Standard solution, respectively: not more than 0.2% of torsemide related compound C, not more than 0.3% of torsemide related compound B, and not more than 0.5% of torsemide related compound A are found. Calculate the percentage of any other impurity in the portion of Torsemide taken by the formula:

100(r_i/rₛ)

in which r_i is the peak response for each other impurity obtained from the Test solution; and rₛ is the sum of the responses of all the peaks obtained from the Test solution: not more than 0.1% of any other impurity is found, not more than 0.2% of total other impurities is found, and not more than 1.0% of total impurities (including torsemide related compounds A, B, and C) is found.

4 Assay

0.02 M Potassium phosphate buffer - Dissolve 2.7 g of monobasic potassium phosphate in about 900 mL of water. Adjust with phosphoric acid to a pH of 3.5, dilute with water to 1000 mL, and mix.

Mobile phase - Prepare a filtered and degassed mixture of 0.02 M Potassium phosphate buffer and methanol (3:2). Make adjustments if necessary (see System Suitability under Chromatography 〈621〉).

Standard preparation - Transfer about 19 mg of USP Torsemide RS, accurately weighed, to a 50-mL volumetric flask, add 15 mL of methanol, mix, and sonicate for not less than 8 minutes. Add 22.5 mL of 0.02 M Potassium phosphate buffer, cool to room temperature, dilute with Mobile phase to volume, and mix.

Assay preparation - Transfer about 38 mg of Torsemide, accurately weighed, to a 100-mL volumetric flask, add 30 mL of methanol, mix, and sonicate for not less than 8 minutes. Add 45 mL of 0.02 M Potassium phosphate buffer, cool to room temperature, dilute with Mobile phase to volume, and mix.

Chromatographic system (see Chromatography 〈621〉) - The liquid chromatograph is equipped with a 288-nm detector and a 4.6-mm × 15-cm column that contains 7-µm packing L1. The flow rate is about 1.5 mL per minute. Chromatograph the Standard preparation, and record the peak responses as directed for Procedure: the tailing factor is not more than 2.0; and the relative standard deviation for replicate injections is not more than 2.0%.

Procedure - Separately inject equal volumes (about 20 µL) of the Standard preparation and the Assay preparation into the chromatograph, record the chromatograms, and measure the responses for the major peaks. Calculate the amount, in mg, of C₁₆H₂₀N₄O₃S in the portion of Torsemide taken by the formula:

100C(rᵤ/rₛ)

in which C is the concentration, in mg/mL, of USP Torsemide RS in the Standard preparation; and rᵤ and rₛ are the peak responses obtained from the Assay preparation and the Standard preparation, respectively.